Uncategorized

Regeneron deepens relationship with CytomX, adding up to $2B and eight targets

Published

on

All told, CytomX Therapeutics now stands to receive up to $4 billion over the course of its partnership with Regeneron, if all milestones are met.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version